CXCL10/CXCR3 overexpression as a biomarker of poor prognosis in patients with stage II colorectal cancer

Author：      

Publisher： Science Publishers

ISSN： 2049-9450

Source： Molecular and Clinical Oncology, Vol.4, Iss.1, 2016-01, pp. : 23-30

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Co-expression of CXCR4 and CD133 proteins is associated with poor prognosis in stage II-III colon cancer patients

By                

Experimental and Therapeutic Medicine, Vol. 3, Iss. 6, 2012-01 ,pp. : 973-982

Spandidos Publications

Access to resources Recommend Favorite

Overexpression of CPE-∆N predicts poor prognosis in colorectal cancer patients

By Zhou Kun   Liang Hongyan   Liu Yang   Yang Chun   Liu Peijia   Jiang Xiaofeng  

Tumor Biology, Vol. 34, Iss. 6, 2013-12 ,pp. : 3691-3699

Springer Publishing Company

Access to resources Recommend Favorite

SASS6 overexpression is associated with mitotic chromosomal abnormalities and a poor prognosis in patients with colorectal cancer

By                          

Oncology Reports, Vol. 34, Iss. 2, 2015-01 ,pp. : 727-738

Spandidos Publications

Access to resources Recommend Favorite

Galanin plays an important role in cancer invasiveness and is associated with poor prognosis in stage II colorectal cancer

By  

Oncology Reports, Vol. 33, Iss. 2, 2015-01 ,pp. : 539-546

Spandidos Publications

Access to resources Recommend Favorite

Stromal CXCR4 and CXCL12 Expression is Associated with Distant Recurrence and Poor Prognosis in Rectal Cancer After Chemoradiotherapy

By Saigusa Susumu  

Annals of Surgical Oncology, Vol. 17, Iss. 8, 2010-08 ,pp. : 2051-2058

Springer Publishing Company

Access to resources Recommend Favorite